Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Acorda Therapeutics Selected to be Inaugural Member of the NASDAQ NeuroInsights Neurotech Index
October 8th, 2007
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that is has been selected to be an inaugural member of NASDAQ NeuroInsights(R) Neurotech(R) Index. The NASDAQ NeuroInsights Neurotech Index is the first index designed to track the performance of leading neurotechnology companies that are listed and actively traded on one of the three major U.S. stock exchanges. The NASDAQ NeuroInsights Neurotech Index includes companies engaged in researching, developing, manufacturing and marketing pharmaceuticals, biologics, medical devices and diagnostics for the brain and nervous system. In addition to meeting minimum market criteria, the 32 companies included in the index must be...
Source: Biotech Business Week (2007-10-08)
|
